Daniel_Walter

Daniel G. Walter

Consumer Safety Officer, FDA/CDRH

Daniel Walter is currently the Chief of the Foreign Enforcement Branch in the Division of International Compliance Operations within the Office of Compliance, Center for Devices and Radiological Health (CDRH), FDA. The branch oversees the compliance efforts for medical device manufacturers outside the United States, and includes inspection review, recall classification, and administration of allegation of regulatory misconduct, as well as assisting the office, Center, and Agency for cross-cutting initiatives, for all device types. Daniel began his career at FDA as a compliance officer in, then was promoted to the branch chief of, the Vascular and Circulatory Support Branch in the Office of Compliance at CDRH. He is currently acting as the Branch Chief in the Gastroenterology Devices Branch of the Division of Reproductive, Gastro-Renal, and Urological Devices in ODE, working with epidemiologists and Medical Device Reporting analysts in OSB, to develop cross-cutting mechanisms to enhance patient outcomes through information sharing by developing “benefit-risk” based evaluation processes. Prior to working with FDA, Daniel Walter was a Validation Engineer, leading to becoming the Lead Quality Auditor and Director of Quality at DST Controls. Daniel’s experience includes facility, utility, equipment, and process validations for automated and non-automated systems, including for steam and compressed air distribution validations, cleaning validations, self-contained automated manufacturing lines for liquid and solid pharmaceutical manufacturers.

Appearances

  • Thumbnail for CSA - Opportunities for GAMP 5 2nd Edition & 21 CFR Part 11
    Date
    October 16, 2023
    In this session you will hear about how GAMP 5 Second Edition has had an impact on the pharmaceutical industry, the current FDA position on Computer Software Assurance (CSA) including how organizations are adapting to a CSA environment, the significant areas of progress and, conversely the remainin…

    Speakers

    Speaker Image for Ken Shitamoto
    Executive Director, IT - Quality and Compliance, Gilead Sciences
    Speaker Image for Khaled Moussally
    Executive Vice President Clients & Regulatory Relations, Compliance Group Inc
    Speaker Image for Francisco Vicenty
    Program Manager, Case for Quality, FDA/CDRH
    Speaker Image for Heather Watson
    Director, TenTenTen Consulting Ltd
    Speaker Image for Chris Clark
    Director, TenTenTen Consulting Limited
    Speaker Image for Sion Wyn
    Director, Conformity Ltd.
    Speaker Image for Daniel Walter
    Consumer Safety Officer, FDA/CDRH
  • Thumbnail for Hearing from Regulators
    Date
    April 17, 2024
    Regulatory panel discussion on the implications and opportunities of CSA draft guidance and GAMP 5 2nd Edition on 21 CFR Part 11 Since the release of the FDA draft on Computer Software Assurance (CSA), September 13th, 2023, many questions and concerns have been raised regarding the impact of the gu…

    Speakers

    Speaker Image for Kevin Bailey
    GMP Inspector, MHRA
    Speaker Image for Ian Jackson
    Expert GMP Inspector, MHRA
    Speaker Image for Khaled Moussally
    Executive Vice President Clients & Regulatory Relations, Compliance Group Inc
    Speaker Image for Francisco Vicenty
    Program Manager, Case for Quality, FDA/CDRH
    Speaker Image for Daniel Walter
    Consumer Safety Officer, FDA/CDRH